Other Stories

Johnson & Johnson eyes 1 billion doses of potential COVID-19 vaccine by 2021 Updated: 2020-08-12 10:08:48 KST

U.S. company Johnson & Johnson says it could produce one billion doses of its potential COVID-19 vaccine next year if it proves successful.
The company says it will consider testing it on health volunteers if there aren't enough patients for final trials.
Johnson & Johnson started early-stage human safety trials in July after releasing details of a study on monkeys that showed its best-performing candidate offered strong protection in a single dose.
Large-scale trials are set to start in early October.
We should know if it's effective sometime between the end of this year and mid-2021.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.